As of 2026-04-04, the Relative Valuation of Ligand Pharmaceuticals Inc (LGND) is 157.66 USD. This relative valuation is based on P/E multiples. With the latest stock price at 199.59 USD, the upside of Ligand Pharmaceuticals Inc based on Relative Valuation is -21.0%.
The range of the Relative Valuation is 133.78 - 180.75 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 29.0x | 26.2x |
| Forward P/E multiples | 21.7x - 28.2x | 24.5x |
| Fair Price | 133.78 - 180.75 | 157.66 |
| Upside | -33.0% - -9.4% | -21.0% |
| Date | P/E |
| 2026-04-02 | 31.98 |
| 2026-04-01 | 31.98 |
| 2026-03-31 | 31.99 |
| 2026-03-30 | 30.86 |
| 2026-03-27 | 31.32 |
| 2026-03-26 | 32.64 |
| 2026-03-25 | 32.77 |
| 2026-03-24 | 32.31 |
| 2026-03-23 | 32.10 |
| 2026-03-20 | 32.81 |
| 2026-03-19 | 33.72 |
| 2026-03-18 | 33.57 |
| 2026-03-17 | 33.81 |
| 2026-03-16 | 33.29 |
| 2026-03-13 | 32.51 |
| 2026-03-12 | 33.88 |
| 2026-03-11 | 35.45 |
| 2026-03-10 | 34.01 |
| 2026-03-09 | 33.35 |
| 2026-03-06 | 32.35 |
| 2026-03-05 | 33.05 |
| 2026-03-04 | 33.48 |
| 2026-03-03 | 32.72 |
| 2026-03-02 | 32.45 |
| 2026-02-27 | 31.77 |
| 2026-02-26 | 31.43 |
| 2026-02-25 | 30.66 |
| 2026-02-24 | 30.28 |
| 2026-02-23 | 29.42 |
| 2026-02-20 | 29.48 |
| 2026-02-19 | 29.85 |
| 2026-02-18 | 30.43 |
| 2026-02-17 | 30.04 |
| 2026-02-13 | 29.45 |
| 2026-02-12 | 29.10 |
| 2026-02-11 | 29.79 |
| 2026-02-10 | 29.96 |
| 2026-02-09 | 29.95 |
| 2026-02-06 | 30.51 |
| 2026-02-05 | 30.71 |
| 2026-02-04 | 31.78 |
| 2026-02-03 | 31.86 |
| 2026-02-02 | 31.71 |
| 2026-01-30 | 30.78 |
| 2026-01-29 | 31.27 |
| 2026-01-28 | 30.48 |
| 2026-01-27 | 31.32 |
| 2026-01-26 | 31.76 |
| 2026-01-23 | 32.23 |
| 2026-01-22 | 32.66 |